Background Investigation Methods
SEC chair outlines ‘Project Crypto’ vision and approach for digital asset regulation
On November 12, SEC Chair Paul S. Atkins spoke at the Federal Reserve Bank of Philadelphia, describing the agency’s evolving approach t...
Hikma Announces Launch of Stelara® (ustekinumab) Biosimilar Starjemza™
On November 6, 2025, Hikma announced the U.S. launch of Starjemza™ (ustekinumab-hmny), a biosimilar of Janssen / Johnson & Johnson’...
Choosing the Right eDiscovery Platform for Your Firm
Selecting the right eDiscovery platform is one of the most important technology decisions a legal team can make. With data volumes grow...
FDA Approves Shanghai Henlius’s Interchangeable Pertuzumab Biosimilar
On November 13, 2025, the FDA approved Shanghai Henlius Biologics Co. Ltd.’s POHERDY (pertuzumab-dpzb) as an interchangeable biosimilar...
Senate agriculture committee publishes bipartisan discussion draft proposing a CFTC-led digital commodity regulatory framework
On November 10, Senate Agriculture Committee Chairman John Boozman (R-AR) and Senator Cory Booker (D-NJ) released a bipartisan discuss...
The High Stakes of Attorney-Client Privilege in the Digital Age: eDiscovery Best Practices
In the digital age, you can’t underestimate the high stakes of attorney-client privilege. Nextpoint discusses that in the first of a th...
CMS announces voluntary “GENEROUS” Medicaid most-favored-nation drug pricing model, planned to launch in 2026
On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model designed to make Most Fa...
Fed’s Barr discusses AI adoption by banks and its risks
On November 11, the Fed’s Michael Barr addressed a fintech festival, highlighting the Fed’s focus on AI as it reshapes the economy and ...
Revised pre-RFD guidance reflects FDA’s efforts to clarify pre-RFD process
The U.S. Food and Drug Administration (FDA) recently revised its final guidance, How to Prepare a Pre-Request for Designation (Pre-RFD)...
Life Sciences New in Italy: October 2025
Regulatory - European Commission adopts rules for joint clinical assessments of medical devices and in vitro diagnostic medical device...